Literature DB >> 14557653

Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells.

Daniel Oberg1, Brian Collier, Xiaomin Zhao, Stefan Schwartz.   

Abstract

Here we show that the 5' end and the middle region of the L2 coding sequence of human papillomavirus type 16 contain strong inhibitory RNA sequences termed inhibitory regions I and II. This is in contrast to L1, which contains one inhibitory region in the 5' end of the coding region. Inhibitory regions I and II acted in cis to reduce L2 mRNA levels and to inhibit the use of the mRNA. In tandem, the two regions reduced L2 mRNA production to undetectable levels. Specific mutational inactivation of the two inhibitory elements in the 5' end and in the middle region of L2 by the introduction of nucleotide substitutions that changed the nucleotide sequence but not the protein sequence resulted in production of high levels of L2 mRNA and protein. In contrast to L2, a partial L1 mutant in which only the first one third of L1 was mutated produced levels of L1 mRNA and protein similar to those in a full L1 mutant. In addition, the constitutive transport element of simian retrovirus type 1 overcomes the effect of the inhibitory sequences of L1 but not L2.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557653      PMCID: PMC229356          DOI: 10.1128/jvi.77.21.11674-11684.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells.

Authors:  Brian Collier; Daniel Oberg; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.

Authors:  B K Felber; M Hadzopoulou-Cladaras; C Cladaras; T Copeland; G N Pavlakis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

3.  Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line.

Authors:  E R Flores; B L Allen-Hoffmann; D Lee; C A Sattler; P F Lambert
Journal:  Virology       Date:  1999-09-30       Impact factor: 3.616

4.  Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription.

Authors:  Michelle A Ozbun
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

Review 5.  Human papillomavirus life cycle: active and latent phases.

Authors:  F Stubenrauch; L A Laimins
Journal:  Semin Cancer Biol       Date:  1999-12       Impact factor: 15.707

6.  Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes.

Authors:  C Leder; J A Kleinschmidt; C Wiethe; M Müller
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  The human papillomavirus type 31 late 3' untranslated region contains a complex bipartite negative regulatory element.

Authors:  Sarah A Cumming; Claire E Repellin; Maria McPhillips; Jonathan C Radford; J Barklie Clements; Sheila V Graham
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

8.  Codon optimization of the HPV-16 E5 gene enhances protein expression.

Authors:  Gary L Disbrow; Iruvanti Sunitha; Carl C Baker; John Hanover; Richard Schlegel
Journal:  Virology       Date:  2003-06-20       Impact factor: 3.616

9.  Inhibition of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability element in the HPV-1 late 3' untranslated region.

Authors:  Lisa Wiklund; Marcus Sokolowski; Anette Carlsson; Margaret Rush; Stefan Schwartz
Journal:  J Biol Chem       Date:  2002-07-29       Impact factor: 5.157

10.  Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity.

Authors:  Wen Jun Liu; Fengguang Gao; Kong Nan Zhao; Weiming Zhao; Germain J G Fernando; Ranjeny Thomas; Ian H Frazer
Journal:  Virology       Date:  2002-09-15       Impact factor: 3.616

View more
  23 in total

1.  Inhibitory cis-element-mediated decay of human papillomavirus type 16 L1-transcript in undifferentiated cells.

Authors:  Seiichiro Mori; Saori Ozaki; Toshiharu Yasugi; Hiroyuki Yoshikawa; Yuji Taketani; Tadahito Kanda
Journal:  Mol Cell Biochem       Date:  2006-04-01       Impact factor: 3.396

Review 2.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

3.  A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H.

Authors:  Daniel Oberg; Joanna Fay; Helen Lambkin; Stefan Schwartz
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression.

Authors:  Margaret Rush; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein.

Authors:  Xiaomin Zhao; Daniel Oberg; Margaret Rush; Joanna Fay; Helen Lambkin; Stefan Schwartz
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation.

Authors:  Cecilia Johansson; Monika Somberg; Xiaoze Li; Ellenor Backström Winquist; Joanna Fay; Fergus Ryan; David Pim; Lawrence Banks; Stefan Schwartz
Journal:  EMBO J       Date:  2012-05-22       Impact factor: 11.598

Review 7.  Regulation of human papillomavirus gene expression by splicing and polyadenylation.

Authors:  Cecilia Johansson; Stefan Schwartz
Journal:  Nat Rev Microbiol       Date:  2013-03-11       Impact factor: 60.633

8.  Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene.

Authors:  Xiaomin Zhao; Margaret Rush; Stefan Schwartz
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5' splice site, SD3632.

Authors:  Monika Somberg; Xiaomin Zhao; Monika Fröhlich; Magnus Evander; Stefan Schwartz
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

10.  Exonic remnants of whole-genome duplication reveal cis-regulatory function of coding exons.

Authors:  Xianjun Dong; Pavla Navratilova; David Fredman; Øyvind Drivenes; Thomas S Becker; Boris Lenhard
Journal:  Nucleic Acids Res       Date:  2009-12-06       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.